Editing
Disorders of Ejaculation and Orgasm
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Management === * '''<span style="color:#ff0000">Patients with ED and premature ejaculation should have their ED addressed first.''' *'''Based on subtype''' ** '''Lifelong PE: pharmacotherapy alone or in combination with graded levels of patient and couple psychosexual therapy''' ** '''Acquired PE: cause-specific treatment''' (e.g., psychosexual counseling or ED pharmacotherapy, alone or in combination with PE pharmacotherapy). ** '''Variable PE or PE-like ejaculatory dysfunction: psychosexual education and graded patient and couple psychotherapy''' ==== First-line: Psychosexual therapy ==== * '''<span style="color:#ff0000">All men seeking treatment for PE should receive basic psychosexual education or coaching''' * '''Most frequently used treatments (2):''' *#'''Squeeze technique''' *#'''Stop-start technique''' * Efficacy **At laast moderately successful in alleviating the dysfunction in the short term **Long-term outcome data are limited and suggest a significant relapse rate ==== Second-line: Pharmacologic treatment ==== ===== Options ===== * '''<span style="color:#0000ff">PASTA (5):''' # '''<span style="color:#0000ff">P<span style="color:#ff0000">DE5 inhibitors (only if comorbid erectile dysfunction)''' # '''<span style="color:#0000ff">A<span style="color:#ff0000">nesthetic, topical''' # '''<span style="color:#0000ff">S<span style="color:#ff0000">elective serotonin reuptake inhibitors (SSRIs)''' # '''<span style="color:#0000ff">T<span style="color:#ff0000">ramadol''' # '''<span style="color:#0000ff">A<span style="color:#ff0000">lpha-blockers''' * All are considered off-label ====== Phosphodiesterase type 5 (PDE5) inhibitors ====== * '''<span style="color:#ff0000">In males with comorbid erectile dysfunction, erectile dysfunction pharmacotherapy alone or in combination with PE pharmacotherapy is recommended</span>''' for the treatment of lifelong PE or acquired PE * '''In males with normal erectile dysfunction and''' **'''Lifelong PE, PDE5 inhibitors (off-label on-demand or daily dosing) are not recommended''' ** '''Acquired PE, most often secondary to comorbid ED, hyperthyroidism, chronic lower urogenital infection, prostatodynia, or CPPS, appropriate cause-specific treatment alone or in combination with an SSRI is recommended''' ====== Anesthetic, topical ====== * '''Efficacy''' **'''Moderately effective in delaying ejaculation''' *'''Drugs and Dosages''' **'''Available as cream, gel, or spray''' **'''2.5% lidocaine and/or 2.5% prilocaine''' *Application **Apply to penis 20 to 30 minutes pre-intercourse **Wipe off penile cream before engaging in vaginal penetration ====== Selective serotonin reuptake inhibitors (SSRIs) ====== * '''Mechanism of Action: block pre-synaptic axonal reuptake of serotonin''' from the synaptic cleft of central serotonergic neurons by 5-HT transporters, resulting in enhanced 5-HT neurotransmission and stimulation of postsynaptic membrane 5-HT receptors. * '''Ejaculation delay usually occurs within 5-10 days of starting treatment, but the full therapeutic effect may require 2-3 weeks of treatment''' and usually is sustained during long-term use. *'''<span style="color:#ff0000">Drugs and Dosages''' **'''<span style="color:#ff0000">Daily dosing''' ***'''<span style="color:#ff0000">Options: paroxetine, clomipramine, sertraline, fluoxetine, or citalopram.''' **** '''<span style="color:#ff0000">Paroxetine''' *****10-40mg daily *****'''<span style="color:#ff0000">Exerts the strongest ejaculation delay</span>''', increasing IELT approximately 8.8x over baseline **'''On-demand''' ***'''Options: dapoxetine (not available in Canada) or off-label paroxetine, clomipramine, sertraline, and fluoxetine''' **** '''On-demand administration''' 3-6 hours before intercourse is modestly efficacious and well tolerated but is '''associated with substantially less ejaculatory delay than daily treatment''' * '''<span style="color:#ff0000">Adverse effects''' ** Usually minor, start in the first week of treatment, and may gradually disappear within 2-3 weeks. ** '''<span style="color:#ff0000">Includes''' ***'''<span style="color:#ff0000">Fatigue''' ***'''<span style="color:#ff0000">Yawning''' ***'''<span style="color:#ff0000">Mild nausea''' ***'''<span style="color:#ff0000">Diarrhea''' ***'''<span style="color:#ff0000">Perspiration''' *** '''<span style="color:#ff0000">Hypomania''' ****'''Can occur infrequently; treatment with SSRIs should be avoided in men with a history of bipolar depression''' ***** '''SSRIs are associated with a small increase in the risk for suicidal ideation or suicide attempts in youth but not adults.''' ****** '''Caution is suggested in prescribing SSRIs to young adolescents with PE age β€ 18 years, and to males with PE and a comorbid depressive disorder, particularly when associated with suicidal ideation.''' *** '''<span style="color:#ff0000">Weight gain and increased risk of type 2 diabetes</span>''' associated with long-term SSRI use ***'''<span style="color:#ff0000">Priapism</span>'''; rare potential adverse effect of SSRIs ***'''Upper GI bleeding''' ****Platelet serotonin release has an important role in hemostasis and SSRIs, especially with concurrent use of aspirin and NSAIDs, may be associated with increased risk for upper GI bleeding *** '''Abnormal semen parameters''' ****In males with normal semen parameters, paroxetine has been reported to induce '''abnormal sperm DNA fragmentation''' in a significant proportion of patients, without a measurable effect on other semen parameters. *****Fertility potential of a substantial number of men on paroxetine may be adversely affected by these changes in sperm DNA integrity * '''Patients should be advised to avoid sudden cessation or rapid dose reduction of daily dosed SSRIs, which may be associated with an SSRI withdrawal syndrome''' ====== Tramadol ====== ====== Alpha-blockers ======
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information